MOTS-c
ResearchMitochondrial ORF of 12S rRNA-c
- Category
- Longevity & Anti-Aging
- Aliases
- Mitochondrial peptide MOTS-c
- Administration
- Subcutaneous injection
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Effects are generally described as subtle, with some users noting modestly steadier energy.
- 2
3–4 Weeks
Continued use may bring a sense of improved exercise tolerance for some users.
- 3
5–7 Weeks
Metabolic-related changes, where present, tend to build gradually rather than suddenly.
- 4
8–10 Weeks
Some users report modestly easier fat loss when combined with exercise and diet.
- 5
11–15 Weeks
Effects are generally described as background support rather than a distinct sensation.
- 6
16–20 Weeks
Long-term users often describe steadier energy and metabolic function.
- 7
21–24 Weeks
By this stage, users typically evaluate whether metabolic markers or body composition trends justify continued use.
⚠️ Research context only. This is not medical advice and results are not guaranteed.